Cytek Biosciences, Inc.
CTKB
$3.64
$0.041.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.66% | 5.89% | -3.56% | -7.24% | -9.67% |
| Total Receivables | 9.60% | 7.96% | -8.64% | -14.10% | 11.66% |
| Inventory | -16.90% | -28.06% | -30.52% | -24.33% | -21.47% |
| Prepaid Expenses | -5.15% | 16.30% | -13.55% | -9.18% | 3.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.67% | 11.68% | 74.59% | 101.47% | 21.88% |
| Total Current Assets | -2.10% | 1.12% | -7.61% | -9.59% | -8.69% |
|
|
|||||
| Total Current Assets | -2.10% | 1.12% | -7.61% | -9.59% | -8.69% |
| Net Property, Plant & Equipment | -1.75% | -3.86% | -1.67% | -2.03% | -1.88% |
| Long-term Investments | 3.06% | 2.97% | -1.66% | -15.46% | -15.46% |
| Goodwill | 3.06% | 2.97% | -1.66% | -15.46% | -15.46% |
| Total Other Intangibles | -12.68% | -12.81% | -15.64% | -9.56% | -9.78% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.25% | 7.86% | 33.06% | 24.46% | 41.83% |
| Total Assets | -1.92% | 1.02% | -5.43% | -7.87% | -6.20% |
|
|
|||||
| Total Accounts Payable | 67.70% | 82.35% | 14.39% | 3.54% | -29.45% |
| Total Accrued Expenses | 17.04% | 14.20% | 0.88% | -23.27% | -13.53% |
| Short-term Debt | 71.43% | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 82.08% | 41.44% | 61.25% | 24.08% | -21.39% |
| Total Finance Division Other Current Liabilities | 11.11% | 2.69% | 3.76% | 7.77% | 9.28% |
| Total Other Current Liabilities | 11.11% | 2.69% | 3.76% | 7.77% | 9.28% |
| Total Current Liabilities | 21.82% | 20.34% | 6.99% | -2.26% | -1.68% |
|
|
|||||
| Total Current Liabilities | 21.82% | 20.34% | 6.99% | -2.26% | -1.68% |
| Long-Term Debt | -37.85% | -36.29% | -28.80% | -29.33% | -30.75% |
| Short-term Debt | 71.43% | -- | -- | -- | -- |
| Capital Leases | -14.36% | -20.33% | -23.50% | -25.11% | -24.64% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -20.16% | -19.22% | 1.91% | -5.18% | 9.02% |
| Total Liabilities | 3.54% | 2.34% | 1.79% | -6.22% | -1.64% |
|
|
|||||
| Common Stock & APIC | -0.62% | 1.75% | -4.78% | -4.20% | -4.10% |
| Retained Earnings | -31.84% | -20.64% | -29.29% | -62.20% | -48.29% |
| Treasury Stock & Other | 60.81% | 101.25% | 106.40% | 88.91% | -164.74% |
| Total Common Equity | -3.31% | 0.68% | -7.23% | -8.26% | -7.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.31% | 0.68% | -7.23% | -8.26% | -7.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.31% | 0.68% | -7.23% | -8.26% | -7.28% |
|
|
|||||